Ontunisertib not checked
Agomab Spain S.L. · ORG-129 · AGMB-129
FollowEvery change as it happens, and a Monday email
Trials
2 active
7 in total · 5 in the EU
Targets
—
None known yet
What this is
- How it works
- How it works isn't classified yet
- Tested for
- Fibrostenotic Crohn's Disease (2 trials)
- Main trialPhase 2
- “Many patients with Crohn's disease (CD) develop fibrotic narrowing (strictures) in their bowel, causing obstructive symptoms such as abdominal pain, cramping, or vomiting after meals. Because of these symptoms, patients often require bowel resection surgery. The objective of this clinical trial is to evaluate the efficacy, safety, and dose-response relationship of ontunisertib in participants with CD and symptomatic strictures, and contribute to the validation of novel endpoints to assess potential treatment benefit in patients with fibrostenosing Crohn's disease (FSCD). The participants…”In the company’s words, NCT07683325 on ClinicalTrials.gov
- Other names
- ORG-129 · AGMB-129
Other drugs for Fibrostenotic Crohn's Disease
- ObefazimodAbivax S.A. · Phase 3
- TofacitinibPfizer · Phase 3
- RisankizumabAbbVie · Phase 3
- UpadacitinibAbbVie · Phase 3
- UstekinumabJohnson & Johnson (Janssen) · Phase 3
- IcotrokinraJohnson & Johnson (Janssen) · Phase 3
Coming up2
- 31 Jan 2027Phase 1 trial completes · ClinicalTrials.gov
- 31 Dec 2028Phase 2 trial completes · ClinicalTrials.gov
Changes1
Last 90 days- 19 NovCompletion date moved: 2026-09-26 to 2027-01-31 · ClinicalTrials.gov NCT07672574
Trials7
| Trial | Phase | Completes | What it tests |
|---|---|---|---|
| Phase 2Recruiting | 31 Dec 2028 | NOV-ERA - A Clinical Trial to Assess the Efficacy and Safety of Ontunisertib Compared to Placebo in Patients With Fibrostenosing Crohn's Disease | |
| Phase 1Recruiting | 31 Jan 2027 | Human Mass Balance Study of [14C] Ontunisertib in Healthy Volunteers | |
| Phase 2Completed | 20 Jun 2026 | STENOVA - A Study to Evaluate Safety, Tolerability, PK and PD of AGMB-129 in Patients With Fibrostenotic Crohn's Disease | |
| Phase 1Completed | 12 Dec 2022 | First in Human Study of ORG-129 in Healthy Volunteers | |
| Phase 1Completed | 6 Sep 2023 | Drug-Drug Interaction Study With AGMB-129 and Midazolam in Healthy Participants | |
| Phase 1Completed | 8 May 2024 | Relative Bioavailability and Effect of Food Study With AGMB-129 in Healthy Participants | |
| Phase 1Completed | 15 Sep 2025 | A Multiple Ascending Dose Study With AGMB-129 in Healthy Participants |
A trial in both registries shows both numbers.
About
- Sources
- ClinicalTrials.gov updated 19 Nov 2026 · EU trials register (CTIS) updated 19 Nov 2026 · openFDA updated 19 Nov 2026